John L. Ryan

Insider Reports History

Location
New York, NY
Signature
/s/ John Ryan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John L. Ryan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Unicycive Therapeutics, Inc. Director Stock Options 123,775 05 Sep 2023 Direct
Kadmon Holdings, Inc. EVP, Chief Medical Officer Equity Appreciation Rights Unit 0 $3.50 09 Nov 2021 Direct
Kadmon Holdings, Inc. EVP, Chief Medical Officer Stock Option (right to buy) 0 $5.54 09 Nov 2021 Direct

Insider Reports Filed by John L. Ryan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
UNCY Unicycive Therapeutics, Inc. 05 Sep 2023 1 $0 4 Director 07 Sep 2023, 16:32
/report/000110465921136410-ryan-john-l-2021-11-09 Kadmon Holdings, Inc. 09 Nov 2021 6 -$3,200,875 4 EVP, Chief Medical Officer 09 Nov 2021, 16:41
UNCY Unicycive Therapeutics, Inc. 12 Jul 2021 0 $0 3 Director 12 Jul 2021, 17:15